BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38681105)

  • 1. Carbamazepine-induced Stevens-Johnson syndrome progressing to toxic epidermal necrolysis: a rare clinical image.
    Ralte R; Mendhe D
    Pan Afr Med J; 2024; 47():44. PubMed ID: 38681105
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
    Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
    Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier – screening in risk patients is recommended].
    Anastasopoulou S; Komuda M; Presman B; Karlsson M; Tomson T
    Lakartidningen; 2017 Feb; 114():. PubMed ID: 28221394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic epidermal necrosis induced by carbamazepine embedded in the subcutis.
    Liu JJ; Lu SC; Liu JL; Yang HM
    An Bras Dermatol; 2018; 93(4):620-621. PubMed ID: 30066786
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
    Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
    Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome with transition to toxic epidermal necrolysis after carbamazepine administration, heroin and alcohol abuse].
    Petter G; Haustein UF
    Hautarzt; 1999 Dec; 50(12):884-8. PubMed ID: 10663024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
    Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
    Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis more common in nonepileptic patients?
    Dhar S; Todi SK
    Dermatology; 1999; 199(2):194. PubMed ID: 10559602
    [No Abstract]   [Full Text] [Related]  

  • 12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
    Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
    Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment.
    Lee WC; Leung JL; Fung CW; Chung BH; Wong V
    J Child Neurol; 2004 Aug; 19(8):619-23. PubMed ID: 15605473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome triggered by Levetiracetam-Caution for use with Carbamazepine.
    Sawal N; Kanga U; Shukla G; Goyal V; Srivastava AK
    Seizure; 2020 Aug; 80():63-64. PubMed ID: 32540638
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbamazepine-induced toxic epidermal necrolysis in a patient despite testing negative for HLA B*15:02 allele.
    Jiang B; Oh CC; Tan KW; Lee HY
    Ann Acad Med Singap; 2021 Mar; 50(3):258-260. PubMed ID: 33855323
    [No Abstract]   [Full Text] [Related]  

  • 16. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
    Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
    Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years.
    Devi K; George S; Criton S; Suja V; Sridevi PK
    Indian J Dermatol Venereol Leprol; 2005; 71(5):325-8. PubMed ID: 16394456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine-induced toxic epidermal necrolysis: the importance of HLA-B*1502 testing in at-risk populations prior to therapy initiation.
    Sargent B; Juhasz MLW; Joe VC; Lee BA; Rojek NW
    Int J Dermatol; 2021 Jul; 60(7):907-908. PubMed ID: 33608873
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
    Ko TM; Chen YT
    Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin induced toxic epidermal necrolysis.
    Topcu H; Gokcinar D; Akcaboy ZN; Karabeyoglu I; Unal T
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S267-9. PubMed ID: 25518798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.